SELLAS Life Sciences Group, Inc. Common Stock
$8.110
USD
Last updated on --.
24h volume8.38M
24h highest8.3580 USD
24h lowest7.4250 USD
24h Price movement+4.24%
SLS recent prices
24 Hours
+4.24%+$0.33
30 days
+66.19%+$3.230
60 days
+78.01%+$3.405
90 days
+64.84%+$3.190
Key data
Previous close7.7800 USD
Market cap1.67B USD
Volume8.38M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.24030 USD
Next ex-dividend dateMar 24, 2011
Next payment dateApr 5, 2011
EPS diluted (TTM)-0.16000 USD
Net income (FY)-29.46M USD
Revenue (FY)--
Last report dateMay 12, 2026
About SELLAS Life Sciences Group, Inc. Common Stock
HeadquartersNEW YORK
Employees (FY)13.00
Net income per employee (FY)-2.27M USD
Listed onNasdaq
SLS conversion tables
 |  |
|---|---|
| 0.5 SLS | 4.055 USD |
| 1 SLS | 8.110 USD |
| 5 SLS | 40.55 USD |
| 10 SLS | 81.1 USD |
| |
|---|---|
| 0.5 USD | 0.061652 SLS |
| 1 USD | 0.1233 SLS |
| 5 USD | 0.61652 SLS |
| 10 USD | 1.233 SLS |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
SLS is trading at $8.110, +4.24% over the last 24 hours. Track live moves on the price chart at the top of this page.
The SLS stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. SLS is currently trading at $8.110, +4.24% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on SLS price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. SLS's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from SLS; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against SLS's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
SELLAS Life Sciences Group, Inc. Common Stock's market cap is currently 1.67B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume8.38M
24h highest8.3580 USD
24h lowest7.4250 USD
24h Price movement+4.24%
Start trade with SLS Perpetual
Sign up to trade